Alexander Gragerov

Title: Innovations of Alexander Gragerov

Introduction

Alexander Gragerov is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the area of G protein-coupled receptors (GPCRs). With a total of 2 patents, his work has implications for the diagnosis and treatment of various diseases.

Latest Patents

Gragerov's latest patents include "G protein coupled receptor 85 and SREB3 knockout mice and uses thereof." This invention provides GPCR polypeptides and polynucleotides, recombinant materials, and transgenic mice, along with methods for their production. The polypeptides and polynucleotides are useful in diagnosing and treating diseases and disorders. Additionally, the invention offers methods for identifying compounds, such as agonists or antagonists, using the GPCR polypeptides and polynucleotides. It also provides diagnostic assays for detecting diseases associated with inappropriate GPCR activity or levels. Another patent focuses on the "Method of identifying a compound for the treatment or prevention of obesity," which similarly provides valuable tools for research and therapeutic applications.

Career Highlights

Gragerov is currently employed at Omeros Corporation, where he continues to advance his research in GPCRs and their applications in medicine. His work is pivotal in understanding the role of GPCRs in various physiological processes and diseases.

Collaborations

Throughout his career, Gragerov has collaborated with esteemed colleagues, including George A. Gaitanaris and John E. Bergmann. These collaborations have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Alexander Gragerov's innovative work in the realm of GPCRs has the potential to significantly impact medical research and treatment strategies. His contributions are a testament to the importance of innovation in biotechnology.